Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
about
Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantationHigh-risk corneal allografts: A therapeutic challengeGeneration of Tolerogenic Dendritic Cells and Their Therapeutic ApplicationsClinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative EffortRegulatory dendritic cell therapy: from rodents to clinical applicationiPSC-Derived Regulatory Dendritic Cells Inhibit Allograft Rejection by Generating Alloantigen-Specific Regulatory T Cells.Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells.Gram-negative enterobacteria induce tolerogenic maturation in dexamethasone conditioned dendritic cellsGeneration and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transferA Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation.Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation.Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients.Donor bone marrow-derived dendritic cells prolong corneal allograft survival and promote an intragraft immunoregulatory milieu.Dendritic cells and multiple sclerosis: disease, tolerance and therapy.Redefining Strategies to Introduce Tolerance-Inducing Cellular Therapy in Human beings to Combat Autoimmunity and Transplantation Reactions.Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles.Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.Exploring cell-based tolerance strategies for hand and face transplantation.Tolerogenic dendritic cell therapy in organ transplantation.The Immunosuppressant Protosappanin A Promotes Dendritic Cell-Mediated Expansion of Alloantigen-Specific Tregs and Prolongs Allograft Survival in Rats.Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers?Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease.Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study.Co-delivery of autoantigen and dexamethasone in incomplete Freund's adjuvant ameliorates experimental autoimmune encephalomyelitis.Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?Generation of suppressive blood cells for control of allograft rejection.Additive effects of rapamycin and aspirin on dendritic cell allostimulatory capacity.Advance in Targeted Immunotherapy for Graft-Versus-Host Disease.Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance Via Antigen-Specific T Regulatory Type 1 Cells.March1-dependent modulation of donor MHC II on CD103 dendritic cells mitigates alloimmunity
P2860
Q21284774-9325843A-BB3A-4739-ADBF-D76054724569Q26751483-45A68047-9B38-482B-9AE2-5662C9281674Q26764855-69477169-F2DC-4F5B-A351-96D906E81F00Q26773299-EDAE0FE2-DD7D-436F-8A8C-DB2B04E3CA44Q27025996-E2AF9AFE-F1B0-40F6-802C-54B439E131BAQ33659263-600F6C2E-232D-4E29-ABA1-ADE304756D5CQ34379951-1C7107F4-8C5C-489A-8BFA-0E3C55E635C2Q34540737-3F29DA8A-A4A0-4053-A73B-6B0CC560650AQ35571114-B4394E12-36D8-4D56-B50D-DDFFFBAA5A74Q35903062-1010F593-BE31-45A9-B985-C99FCE10A9D0Q36238593-54DCC115-9367-48CA-8A1B-CF21D934C33AQ36919825-2740DF75-099D-4E51-A343-50F90354F9B6Q37316849-356D801F-EC48-40FC-A74A-1346A2A9D2ABQ38070093-7B218954-CF6E-4857-9A06-80FC2B608AAEQ38245229-ED4DECDF-5EE3-4D58-8DF0-3133F20C616CQ38256369-65410777-CB39-4286-B000-14F726CA79F2Q38339535-B9ECA953-747D-4DDA-BA3C-B6534EAC27B6Q38569715-FF420733-9939-4D2D-B242-8653E8DD5EE1Q39013872-929B9D65-BCE6-453E-9EF4-58C5AC74F468Q41582051-7251A502-46AC-419F-BAAB-19EC8E7F1DADQ42428575-CFBB946A-6B71-41D6-8E25-EEF3ABD0B699Q42694613-28B2847D-A0C4-430F-A926-5B35778AB4C5Q42907197-17E63EC9-BEFE-42B8-B384-589DA3F4DC56Q47617033-87719E7A-21BC-4BA3-97EB-403FFCC2C2F7Q52665595-FD9CABF2-1D26-407C-8B8A-B6964EB317FBQ52993941-CE54C5F5-17C4-4AF3-BC52-1F66F7977F95Q53311604-998CA16F-50C1-4174-BBC6-EC8ADC48B974Q54937398-814BF923-2DFF-4ECF-9407-8972EBD48459Q55013923-5AD72113-58A6-4D19-8A02-ECB20F8CF483Q58699588-EB5B13DF-2278-428E-855A-F3965D8B79F3
P2860
Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@ast
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@en
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@en-gb
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@nl
type
label
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@ast
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@en
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@en-gb
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@nl
prefLabel
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@ast
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@en
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@en-gb
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@nl
P2093
P2860
P3181
P356
P1476
Tolerogenic dendritic cells an ...... rom rodents to clinical trials
@en
P2093
Aurélie Moreau
Emilie Varey
Gaëlle Bériou
Laurence Bouchet-Delbos
Maria-Cristina Cuturi
Mercedes Segovia
P2860
P3181
P356
10.3389/FIMMU.2012.00218
P407
P50
P577
2012-01-01T00:00:00Z